These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 6692381

  • 1. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
    Tan CT, Hancock CH, Mondora A, Hoffman NW.
    Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phase I study of aziridinylbenzoquinone (NSC 182986).
    Bedikian AY, Bodey GP, Burgess MA, Freireich EJ.
    Cancer Clin Trials; 1981 Feb; 4(4):459-63. PubMed ID: 7318128
    [Abstract] [Full Text] [Related]

  • 6. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
    Murren J, Modiano M, Clairmont C, Lambert P, Savaraj N, Doyle T, Sznol M.
    Clin Cancer Res; 2003 Sep 15; 9(11):4092-100. PubMed ID: 14519631
    [Abstract] [Full Text] [Related]

  • 7. Phase II study of continuous-infusion diaziquone in relapsed/refractory acute nonlymphocytic leukemia.
    Schulman P, Davis R, Lee E, Ellerton J, Staszweski H.
    Cancer Treat Rep; 1987 Sep 15; 71(7-8):755-7. PubMed ID: 3607786
    [Abstract] [Full Text] [Related]

  • 8. Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.
    Griffin JP, Newman RA, McCormack JJ, Krakoff IH.
    Cancer Treat Rep; 1982 Jun 15; 66(6):1321-5. PubMed ID: 7083235
    [Abstract] [Full Text] [Related]

  • 9. Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992) in children with acute leukemia and lymphoma.
    Tan CT, Hancock C, Steinherz PG, Steinherz LJ, Sorell M, Chan KW, Mondora A, Miller DR.
    Cancer Res; 1982 Apr 15; 42(4):1579-81. PubMed ID: 6895864
    [Abstract] [Full Text] [Related]

  • 10. Phase I and clinical pharmacological study of 4-demethoxydaunorubicin (idarubicin) in children with advanced cancer.
    Tan CT, Hancock C, Steinherz P, Bacha DM, Steinherz L, Luks E, Winick N, Meyers P, Mondora A, Dantis E.
    Cancer Res; 1987 Jun 01; 47(11):2990-5. PubMed ID: 3471321
    [Abstract] [Full Text] [Related]

  • 11. A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinoma.
    Rubin J, van Hazel GA, Schutt AJ, Moertel CG, O'Connell MJ.
    Am J Clin Oncol; 1982 Oct 01; 5(5):539-40. PubMed ID: 7180832
    [Abstract] [Full Text] [Related]

  • 12. Phase II clinical evaluation of AZQ in metastatic breast cancer.
    Yap HY, Bedikian AY, Schell FC, Blumenschein GR, Bodey GP.
    Am J Clin Oncol; 1983 Feb 01; 6(1):31-3. PubMed ID: 6837505
    [Abstract] [Full Text] [Related]

  • 13. Phase I clinical investigation of benzisoquinolinedione (amonafide) in adults with refractory or relapsed acute leukemia.
    O'Brien S, Benvenuto JA, Estey E, Beran M, Felder TB, Keating M.
    Cancer Res; 1991 Feb 01; 51(3):935-8. PubMed ID: 1988134
    [Abstract] [Full Text] [Related]

  • 14. Phase I clinical and pharmacokinetic study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide in children with cancer.
    Rivera G, Evans WE, Dahl GV, Yee GC, Pratt CB.
    Cancer Res; 1980 Nov 01; 40(11):4250-3. PubMed ID: 6258775
    [Abstract] [Full Text] [Related]

  • 15. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP, Preisler HD, Slocum H, Rustum YM.
    Cancer Res; 1982 Apr 01; 42(4):1587-94. PubMed ID: 6949642
    [Abstract] [Full Text] [Related]

  • 16. Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.
    Greenberg HS, Ensminger WD, Layton PB, Gebarski S, Meyer M, Chaffee B, Bender JF, Grillo-Lopez AJ.
    Cancer Treat Rep; 1986 Mar 01; 70(3):353-7. PubMed ID: 3006913
    [Abstract] [Full Text] [Related]

  • 17. Phase I trial of 5-day continuous infusion aziridinylbenzoquinone (AZQ, diazaquone, NSC 182968).
    Sigman LM, Van Echo DA, Whitacre MY, Aisner J, Budman DA, Shulman P.
    Am J Clin Oncol; 1986 Feb 01; 9(1):79-82. PubMed ID: 3953494
    [Abstract] [Full Text] [Related]

  • 18. Phase II clinical evaluation of AZQ in colorectal cancer.
    Bedikian AY, Stroehlein JR, Karlin DA, Korinek J, Bodey GP.
    Am J Clin Oncol; 1982 Oct 01; 5(5):535-7. PubMed ID: 7180831
    [Abstract] [Full Text] [Related]

  • 19. Phase II study of aziridinylbenzoquinone in refractory lymphoma.
    Case DC, Hayes DM.
    Cancer Treat Rep; 1983 Nov 01; 67(11):993-6. PubMed ID: 6357437
    [Abstract] [Full Text] [Related]

  • 20. A phase I trial of aziridinylbenzoquinone (NSC 192986) in patients with previously treated acute leukemia.
    Van Echo DA, Schulman P, Budman DR, Ferrari A, Wiernik PH.
    Am J Clin Oncol; 1982 Aug 01; 5(4):405-10. PubMed ID: 7113963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.